MMED:CC News and Press, MIND MEDICINE INC. From 08/23/22

IIROC Trade Resumption - MMED Canada NewsWire TORONTO , Aug. 23, 2022 /CNW/ - Trading resumes in: Company: MIND MEDICINE (MINDMED) INC. NEO Exchange Symbol: MMED All Issues: No Resumption (ET): 9:39:10 AM IIROC can make a decision to i...

IIROC Trading Halt - MMED Canada NewsWire TORONTO , Aug. 23, 2022 /CNW/ - The following issues have been halted by IIROC: Company: MIND MEDICINE (MINDMED) INC. NEO Exchange Symbol : MMED All Issues: Yes Reason: Single-Stock Circuit...

Psychedelic research has seen a significant surge in the past few years amid increased interest in psychedelics among the scientific community and the general public. Companies like Mind Medicine (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) are developing psychedelic-inspired medicines and therapi...

MindMed Strengthens Board with Appointment of Two New Independent Directors Canada NewsWire NEW YORK , Aug. 12, 2022 /CNW/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company"), a clinical stage biopharmaceutical company developing novel pr...

MindMed Reports Second Quarter 2022 Financial Results and Business Highlights Canada NewsWire – Phase 2b dose-optimization trial in patients with General Anxiety Disorder underway with first patient dosing expected in Q3 2022 – – Advanc...

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – August 10, 2022 – Toronto’s Center for Addiction and Mental Health (CAMH) just received the first-ever federal grant to study whether the active component of “magic...

MindMed Board of Directors Approves Reverse Share Split Canada NewsWire NEW YORK , Aug. 4, 2022 /CNW/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel pr...

MindMed to Host Earnings Call to Discuss Second Quarter 2022 Financial Results and Provide Business Update Canada NewsWire NEW YORK , Aug. 4, 2022 /CNW/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical ...

MindMed to Participate in the Canaccord Genuity 42nd Annual Growth Conference Canada NewsWire NEW YORK , Aug. 2, 2022 /CNW/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical compa...

MindMed Announces Completion of Share Redesignation Canada NewsWire NEW YORK , June 30, 2022 /CNW/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (NEO: MMED) ("MindMed'' or the "Company") announces that it has completed its previously announced redesignat...